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There is growing evidence indicating that the global 
coronavirus 2019 (Covid-19) pandemic is responsible for 
decreasing both the number of patients admitted for acute 
stroke and the number of patients with acute stroke treated 
by intravenous thrombolysis, mechanical thrombectomy, or 
both [1, 2].
Małopolska Voivodeship (MV) is located in southeastern 
Poland and has a population of 3.36 million, 8.85% of the 
country’s population. In MV, a very small proportion of 
patients with acute stroke are not hospitalised [3]. Accor-
ding to standard procedures, patients with acute stroke are 
admitted to the nearest stroke unit (of the 15-unit Stroke 
Network) in the region, where intravenous thrombolysis will 
be performed. Those fulfilling the criteria for mechanical 
thrombectomy are admitted to the Comprehensive Stroke 
Unit at the University Hospital in Krakow. The number of 
patients with acute stroke admitted to hospitals without 
neurological departments is now very small. In 2019, of 
6,255 patients diagnosed with acute stroke in MV (according 
to ICD-10: I61, I62, I63, I64), 1,055 (16.9%) received intra-
venous thrombolysis, and 155 (2.5%) received mechanical 
thrombectomy.
The first case of Covid-19 in Poland was diagnosed on 
4 March, 2020, and the country was locked down six days later. 
The number of people in MV diagnosed with Covid-19 by 
the end of May 2020 was 1,215. Of those, 397 (32.7%) were 
hospitalised at the University Hospital, which is the only 
hospital in MV dedicated to treating Covid-19. In spite of the 
pandemic, the number of beds available in the Stroke Network 
was adequate. The four-step process of lifting restrictions due 
to Covid-19 began on 20 April, 2020.
We examined all stroke admissions from January to May 
2020 inclusive. We found that stroke admissions between 
January and April decreased by 19.4% and admissions to 
Stroke Units decreased by 24.6%. Furthermore, the percentage 
treated using intravenous thrombolysis decreased by 32% (Tab. 
1). In May, when Covid-19 restrictions began to be lifted, we 
noted an increase in stroke admissions and in treatment with 
intravenous thrombolysis (Tab. 1). 
Interestingly, the percentage treated with mechanical 
thrombectomy was 25% lower between January and May 
2020 (n = 74) compared to the same period in 2019 (n = 99).
During the Covid-19 pandemic, the number of stroke 
admissions and the number of patients treated with intrave-
nous thrombolysis or mechanical thrombectomy during the 
lockdown period were significantly lower compared to the 
previous year. 
We speculate that patients with relatively mild strokes 
avoided hospitalisation for fear of contracting COVID-19. 
Alternatively, the incidence of stroke might have decreased 
during the pandemic due to unrecognised factors related to 
lockdown rules. 
To determine which of these possibilities is the more 
likely, the clinical characteristics of stroke patients admitted 
during the pandemic should be compared to those of patients 
admitted prior to the pandemic.
2Neurologia i Neurochirurgia Polska 2020, vol. 54
www.journals.viamedica.pl/neurologia_neurochirurgia_polska
Ethical permissions: Ethical approval was not necessary for 
the preparation of this article. 
Funding: This publication was prepared without any external 
source of funding.
Acknowledgement: We thank Mrs. Elżbieta Fryźlewicz-Chra-
pisinska, Director of the National Health Fund, Malopolska 
Regional Division, for supplying data on stroke incidence and 
treatment in Malopolska Voivodeship.
Disclosures: Dr Słowik reports receiving honoraria, lecture 
fees and serving on an advisory board for Bayer, Boehringer 
Ingelheim, Medtronic, Novartis and Biogen. Dr Nowak reports 
receiving honoraria and lecture fees from Novartis and Biogen.
Table 1. Stroke incidence and treatment by intravenous thrombolysis in Malopolska Voivodeship from January to May 2020 inclusive






January and May 
2020
Number of strokes 603 523 507 486  493 –19.4% –18..2%
Number treated in the Stroke Network 556 489 472 419 451 –24.6% –18.9%
Number treated with intravenous 
thrombolysis
97 98 77 66 76 –32.0% –21.6%
Percentage treated with intravenous 
thrombolysis (%)
16.0 18.7 15.2 14.1 15.4 – –
Percentage treated with intravenous 
thrombolysis in the Stroke Network (%)
17.4 20,0 16.3 15.8 16.9 – –
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